Our vision is to significantly reduce 'Variants of Uncertain Significance' in clinical practice. We transform VUS results, which create patient anxiety and clinical uncertainty, into definitive, actionable insights that enable confident clinical decision-making.
A significant percentage of genetic tests—up to 40% in some hereditary cancer panels—return Variants of Uncertain Significance (VUS) results, creating challenges for patients and clinicians.
VUS results create anxiety and uncertainty. Patients have identified genetic variants but lack clear guidance on their clinical significance.
VUS results limit clinical decision-making. Clinicians must rely on family history and population-level risk assessment rather than precise genetic information.
VUS results can lead to increased surveillance, unnecessary procedures, and healthcare costs due to uncertainty-driven medical decisions.
We address VUS through advanced computational analysis and machine learning. Our approach evaluates every variant from first principles using comprehensive biological context rather than relying solely on existing variant databases.
Our operational approach is a multi-stage process designed for maximum impact. Each step builds upon the last, creating a cascade of strategic advantage.
We are your outsourced certainty engine. We take your most ambiguous cases and deliver the clear, actionable answers your clinicians and patients are desperate for. This is a high-margin service that closes your "actionability gap."